近日,在马德里举办的第13届糖尿病先进技术与治疗大会(ATTD)期间,雅培公司公布了四篇真实世界数据摘要。1-4 这些最新数据表明,辅理善瞬感系统能够改善用户的葡萄糖控制3、增加葡萄糖目标范围内时间3、降低出现高血糖4和低血糖4的时间,并且能够降低HbA1c1-2(3个月内的平均葡萄糖水平)。2
雅培国际社区医疗卫生和数学业务部行业副霸道总裁裁兼胃癌护理管理业务部总裁社区医疗卫生官、医美博士生Mahmood Kazemi认为:“当做国际技術领先的由于传感测器器的夏黑葡萄糖注射液检测技術,雅培辅理善瞬感软件拥用200几万顾客,哪些德奥达的实际全世界内容确认并展示出了辅理善瞬感软件创造的临床试验获利。他们一回再添回地了解到颇具意义上的统计资料反复体现他们的技術对调理胃癌患病者健康保健导致的立即决定,胃癌高级技術与制疗洽谈会的探索导致也彰显了他们为持续时间变动客户家庭生活而做的奋斗。” 以下的提要在心脏病先进典型能力与诊治大会议主持稿发布:使用辅理善瞬感有助于改善1型糖尿病或2型糖尿病患者的HbA1c控制水平
针对在瑞典国际糖尿病注册中心登记的成人1型糖尿病和2型糖尿病患者,开展有关辅理善瞬感系统的真实世界研究
加拿大使用辅理善瞬感对血糖控制影响的真实世界数据分析
在美国,动态葡萄糖监测(CGM)的使用与急性糖尿病并发症减少之间存在关联,即便患者之前很少使用试纸也是如此
现在,46个国家和地区的超过200万名糖尿病患者已开始使用雅培辅理善瞬感系统10。36个国家和地区的患者在使用辅理善瞬感系统时可获得部分或全额报销,其中包括法国、爱尔兰、日本、英国和美国。
关于辅理善瞬感系统
雅培辅理善瞬感系统是全球领先的基于传感器的葡萄糖监测技术11,旨在改变糖尿病患者测量葡萄糖水平的方式,从而帮助他们获得更好的健康结果。12 该系统通过可佩戴在上臂背部的传感器读取组织间液葡萄糖水平,无需指尖采血。13
关于雅培
雅培当做世界上十大排名医疗保障卫生设备安全营养健康的服务业干部者,帮助到大众在灵魂各的时候活得那么美好。他们为灵魂安全营养健康的受到前沿性科学,世界上领先的产品遍布全国的诊断、医疗保障卫生设备设备、莒养品、制剂等医疗保障卫生设备安全营养健康的方向。雅培世界上十大排名107,000名店员,帮助世界上160个国家的和中北部的大众活出出彩。雅培在中国拥有超过6,000多名员工, 总部位于上海。了解更多雅培公司信息,敬请登录公司网站拼搏体育:rodelflores.com和。
热情接待瞩目雅培全国公司的qq微信abbott_China。 雅培中国大主流媒体搞好关系人 陆晋美 电活:(021) 23204346 朱一鸣 油箱:alexander.zhu@abbott.com 通话:(021) 231549271Real-world study of FreeStyle Libre system among adults with Type 1 and Type 2 dꦺiabetes within the Swedish National Diabetes Register; Katarina Eeg-Olofsson, Ann-Marie Svensson, Stefan Franzén, Hodan Ahmed Ismail, Michael Törnblom, Fleur Levrat-Guillen
2Improving HbA1c control in people with Type 1 or Type 2 diabetes using flash glucose monitoring: a retrospective observational analysis in two German centers; Gerhard Klaus🔥mann, Ludger Rose, Alexander Seibold
3Canadian real-world analysis of flash glucose monitoring and glycemic control; Lori Berard,Laura Brandner
4Acute diabetes complications defined by hypoglycemia, hypoglyc🔴emic coma, hyperglycemia, ketoacidosis, or hyperosmolarity ICD-10 codes as primary diagnosis for inpatient or as any position in the outpatient emergency claim; Matthew Kerr, Gregory Roberts, Diana Souto, Yele🍨na Nabutovsky
5American Diabetes Association(ADA),
6The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, The New England Journal of Medicine, September 30, 1993, Volume 329, Number 14
7ADA, Internationꦬal Consensus on Time-In-Range. The group recommends a target range of 70-180 mg/dL [3.9-10.0 mmol/L] for individuals with Type 1 diabetes an✃d Type 2 diabetes, and 63-140 mg/dL [3.5-7.8 mmol/L] during pregnancy, along with a set of targets for the time per day
8Expanded real-world use confirms strong association between frequency of flash glucose monitoring and glucose control. Presented at the 12th Advanced Technologies & Treatmentജs for Diabetes (ATTD) in Berlin, Germany⛦; Lang, SR Jangam
9Compared outcomes before and after purchase of continuous glucos🥃e monitoring
10Data on file, Abbott Diabetes Care
11Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre system compared to the n🍨umber of users for other leading personal use, sensor-based glucose monitoring systems
12Bolinder, Jan, et al. Novel glucose-sensing technology and hypoglycemia in Type 1 di♔abetes: a multi-center, non-masked, rꦛandomized controlled trial. The Lancet 388.10057 (2016): 2254-2263
13A fingerstick test using a glucometer is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels; or if hypoglycemia or impending hypoglycemia is reported by the system; or when symptoms do not match the🌳 system readings